282 related articles for article (PubMed ID: 19838016)
1. [Changes in the concept of neuroendocrine tumor].
Sasano H
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1602-5. PubMed ID: 19838016
[TBL] [Abstract][Full Text] [Related]
2. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
[TBL] [Abstract][Full Text] [Related]
4. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A expression in human colonic adenocarcinoma.
Romeo R; Pellitteri R; Mazzone V; Marcello MF
Ital J Anat Embryol; 2002; 107(3):177-83. PubMed ID: 12437144
[TBL] [Abstract][Full Text] [Related]
8. Primitive small cell tumor with epithelial, gangliocytic, neuroendocrine, and mesenchymal differentiation: report of 2 cases.
Michal M; Kazakov DV; Síma R; Vanecek T
Int J Surg Pathol; 2007 Oct; 15(4):429-36. PubMed ID: 17913955
[TBL] [Abstract][Full Text] [Related]
9. Tumour biology and histopathology of neuroendocrine tumours.
Klöppel G
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
Lindholm DP; Oberg K
Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
[TBL] [Abstract][Full Text] [Related]
11. Composite glandular-endocrine cell carcinomas of the stomach: clinicopathologic and methylation study.
Lee EJ; Park SM; Maeng L; Lee A; Kim KM
APMIS; 2005 Sep; 113(9):569-76. PubMed ID: 16218931
[TBL] [Abstract][Full Text] [Related]
12. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
[TBL] [Abstract][Full Text] [Related]
13. Primary mesenteric malignant mixed mesodermal (müllerian) tumor with neuroendocrine differentiation.
Cokelaere K; Michielsen P; De Vos R; Sciot R
Mod Pathol; 2001 May; 14(5):515-20. PubMed ID: 11353063
[TBL] [Abstract][Full Text] [Related]
14. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic endocrine cells in prostatic carcinoma: a case report with immunocytochemical and electron microscopic findings.
Watanabe K; Hoshi N; Hiraki H; Yamaki T; Tsu-Ura Y; Suzuki T
Fukushima J Med Sci; 1995 Jun; 41(1):51-60. PubMed ID: 8606042
[TBL] [Abstract][Full Text] [Related]
16. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.
Klimstra DS; Modlin IR; Adsay NV; Chetty R; Deshpande V; Gönen M; Jensen RT; Kidd M; Kulke MH; Lloyd RV; Moran C; Moss SF; Oberg K; O'Toole D; Rindi G; Robert ME; Suster S; Tang LH; Tzen CY; Washington MK; Wiedenmann B; Yao J
Am J Surg Pathol; 2010 Mar; 34(3):300-13. PubMed ID: 20118772
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of histological types of prostatic cancer].
Medvedev VL; Matsionis AE; Medvedeva LA
Urologiia; 2003; (6):10-4. PubMed ID: 14708236
[TBL] [Abstract][Full Text] [Related]
18. [Definition and histologic characterization of neuroendocrine tumors].
Saint-André JP; Valo I; Guyétant S
Rev Prat; 2002 Feb; 52(3):250-5. PubMed ID: 11925713
[TBL] [Abstract][Full Text] [Related]
19. Biochemical testing for neuroendocrine tumors.
Vinik AI; Silva MP; Woltering EA; Go VL; Warner R; Caplin M
Pancreas; 2009 Nov; 38(8):876-89. PubMed ID: 19855234
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
